{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:18:39Z","timestamp":1750220319907,"version":"3.41.0"},"publisher-location":"New York, NY, USA","reference-count":13,"publisher":"ACM","license":[{"start":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:00:00Z","timestamp":1620950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.acm.org\/publications\/policies\/copyright_policy#Background"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,14]]},"DOI":"10.1145\/3472813.3473218","type":"proceedings-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T15:41:48Z","timestamp":1635262908000},"page":"122-128","source":"Crossref","is-referenced-by-count":0,"title":["Cancer Immunotherapy: Emerging Topics and Future Perspectives"],"prefix":"10.1145","author":[{"given":"Tingting","family":"Xu","sequence":"first","affiliation":[{"name":"Zhejiang Sci-Tech University,Hangzhou,Zhejiang 310018,China, China"}]}],"member":"320","published-online":{"date-parts":[[2021,10,26]]},"reference":[{"key":"e_1_3_2_1_1_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21387"},{"key":"e_1_3_2_1_2_1","volume-title":"Retrieved","author":"Roser Max","year":"2015","unstructured":"Max Roser and Hannah Ritchie . 2015 . Cancer . Retrieved January 26, 2021 from https:\/\/ourworldindata.org\/cancer Max Roser and Hannah Ritchie. 2015. Cancer. Retrieved January 26, 2021 from https:\/\/ourworldindata.org\/cancer"},{"key":"e_1_3_2_1_3_1","doi-asserted-by":"crossref","unstructured":"Mallmann P and Krebs D. 1995. Gewinnung und Aktivierung tumorinfiltrierender Lymphozyten (TIL) im Rahmen einer Lymphokinaktivierten Killerzelltherapie (LAK-TIL-Therapie) bei Patientinnen mit fortgeschrittenen Mamma- und Ovarialkarzinom [Generation and activation of tumor-infiltrating lymphocytes (TIL) within the scope of lymphokine activated killer cell therapy (LAK-TIL therapy) in patients with advanced breast and ovarian carcinoma]. Gynakol Geburtshilfliche Rundsch 35 suppl 1 (1999) 161-165. https:\/\/doi.org\/10.1159\/000272590  Mallmann P and Krebs D. 1995. Gewinnung und Aktivierung tumorinfiltrierender Lymphozyten (TIL) im Rahmen einer Lymphokinaktivierten Killerzelltherapie (LAK-TIL-Therapie) bei Patientinnen mit fortgeschrittenen Mamma- und Ovarialkarzinom [Generation and activation of tumor-infiltrating lymphocytes (TIL) within the scope of lymphokine activated killer cell therapy (LAK-TIL therapy) in patients with advanced breast and ovarian carcinoma]. Gynakol Geburtshilfliche Rundsch 35 suppl 1 (1999) 161-165. https:\/\/doi.org\/10.1159\/000272590","DOI":"10.1159\/000272590"},{"key":"e_1_3_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e3181f05b91"},{"key":"e_1_3_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000848"},{"key":"e_1_3_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-3649"},{"key":"e_1_3_2_1_7_1","volume-title":"Retrospective analysis of adoptive TIL therapy plus anti-PD1 therapy in patients with chemotherapy-resistant metastatic osteosarcoma. J Immunol Res 2020 (October","author":"Zhou Xiang","year":"2020","unstructured":"Xiang Zhou , Junlong Wu , Chunguang Duan , and Yingjie Liu . 2020. Retrospective analysis of adoptive TIL therapy plus anti-PD1 therapy in patients with chemotherapy-resistant metastatic osteosarcoma. J Immunol Res 2020 (October 2020 ), 7890985. https:\/\/doi.org\/10.1155\/2020\/7890985 Xiang Zhou, Junlong Wu, Chunguang Duan, and Yingjie Liu. 2020. Retrospective analysis of adoptive TIL therapy plus anti-PD1 therapy in patients with chemotherapy-resistant metastatic osteosarcoma. J Immunol Res 2020 (October 2020), 7890985. https:\/\/doi.org\/10.1155\/2020\/7890985"},{"key":"e_1_3_2_1_8_1","first-page":"6","article-title":"[Receptor-mediated cancer therapy\u2013tumoricidal cytokines, adoptive therapy of LAK, TIL]","volume":"17","author":"Niitsu Y","year":"1990","unstructured":"Y Niitsu , N Watanabe , H Kondo , and Y Kanisawa . 1990 . [Receptor-mediated cancer therapy\u2013tumoricidal cytokines, adoptive therapy of LAK, TIL] . Gan To Kagaku Ryoho 17 , 6 (June 1990), 1134-1141. https:\/\/pubmed.ncbi.nlm.nih.gov\/1693487\/ Y Niitsu, N Watanabe, H Kondo, and Y Kanisawa. 1990. [Receptor-mediated cancer therapy\u2013tumoricidal cytokines, adoptive therapy of LAK, TIL]. Gan To Kagaku Ryoho 17, 6 (June 1990), 1134-1141. https:\/\/pubmed.ncbi.nlm.nih.gov\/1693487\/","journal-title":"Gan To Kagaku Ryoho"},{"key":"e_1_3_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1129003"},{"key":"e_1_3_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2708"},{"key":"e_1_3_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9061382"},{"key":"e_1_3_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2012.08.001"},{"key":"e_1_3_2_1_13_1","volume-title":"Retrieved","author":"Nuventra","year":"2018","unstructured":"Nuventra 2018 . Monoclonal antibodies: past, present, and future . Retrieved January 26, 2021 from https:\/\/www.nuventra.com\/resources\/blog\/monoclonal-antibodies-past-present-and-future\/ Nuventra 2018. Monoclonal antibodies: past, present, and future. Retrieved January 26, 2021 from https:\/\/www.nuventra.com\/resources\/blog\/monoclonal-antibodies-past-present-and-future\/"}],"event":{"name":"ICMHI 2021: 2021 5th International Conference on Medical and Health Informatics","acronym":"ICMHI 2021","location":"Kyoto Japan"},"container-title":["2021 5th International Conference on Medical and Health Informatics"],"original-title":[],"link":[{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3472813.3473218","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dl.acm.org\/doi\/pdf\/10.1145\/3472813.3473218","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T20:11:57Z","timestamp":1750191117000},"score":1,"resource":{"primary":{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3472813.3473218"}},"subtitle":["This article aims to present major types of cancer immunotherapy, how they are applied, and the future perspectives of this field."],"short-title":[],"issued":{"date-parts":[[2021,5,14]]},"references-count":13,"alternative-id":["10.1145\/3472813.3473218","10.1145\/3472813"],"URL":"https:\/\/doi.org\/10.1145\/3472813.3473218","relation":{},"subject":[],"published":{"date-parts":[[2021,5,14]]}}}